ARTICLE | Company News
Cellectis, Wyss to engineer virus-resistant cells
May 4, 2018 4:18 PM UTC
Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS) and George Church's lab at the Wyss Institute for Biologically Inspired Engineering at Harvard University (Boston, Mass.) partnered to recode the entire genome of cell lines derived from humans and other species. The partners will then engineer the cell lines to be resistant to viral infections.
In previous Science studies, Church and his team showed that removing codons from the Escherichia coli genome conferred viral resistance...